The B1-cell subpopulation is diminished in patients with relapsing-remitting multiple sclerosis

J Neuroimmunol. 2013 Sep 15;262(1-2):92-9. doi: 10.1016/j.jneuroim.2013.06.002. Epub 2013 Jul 12.

Abstract

B cell subsets in newly diagnosed untreated, relapsing-remitting multiple sclerosis (MS) patients were examined. The fraction of CD20(+) B cells was significantly increased in MS. Among subsets of B cells, MS patients had increased frequency of naïve cells, but reduced frequency of memory and B1 cells. The frequencies of B1 cells were inversely correlated with the time since last attack. B1 cells resembled the phenotype of either lymphocytes (CD11b(-) B1 cells) or monocytes (CD11b(+) B1 cells) and a small fraction of cells was CD3(+)CD20(+) by confocal microscopy.

Keywords: B cells; B-cell-depleting antibodies; CD3(+)CD20(+) cells; Human B1 cells; Relapsing–remitting multiple sclerosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antigens, CD20 / biosynthesis
  • B-Lymphocyte Subsets / immunology*
  • B-Lymphocyte Subsets / metabolism
  • B-Lymphocyte Subsets / pathology*
  • CD3 Complex / biosynthesis
  • Down-Regulation / immunology*
  • Female
  • Humans
  • Immunophenotyping
  • Lymphocyte Count
  • Male
  • Multiple Sclerosis, Relapsing-Remitting / immunology*
  • Multiple Sclerosis, Relapsing-Remitting / metabolism
  • Multiple Sclerosis, Relapsing-Remitting / pathology*
  • Up-Regulation / immunology

Substances

  • Antigens, CD20
  • CD3 Complex